Objectives An excessive inflammatory response to SARS-CoV-2 is thought to be a major cause of disease severity in COVID-19. The aim herein was to determine the prognostic value of IL-6, and demonstrate the comparison between IL-6 and related parameters in COVID-19. Methods Data were collected from 115 COVID-19 patients. Results The median age was 46.04 years in the mild group, 56.42 years in the moderate group, and 62.92 years in the severe group (p=0.001). There was a significant difference in the hospitalized clinic to intensive care unit ratio among the patients (p<0.001). The IL-6 values were significantly higher in the severe group than those in the mild (p=0.04) and moderate groups (p=0.043). The area under the receiver operating characteristic curve for IL-6, as predictor of severe clinical condition, was 0.864 (95% CI 0.765–0.963 p=0.000). The longitudinal analyses showed that the severe group presented with significantly increased IL-6 levels during hospitalization. Conclusions IL‐6 seemed to be a guide in the early diagnosis of severe COVID-19 and an ideal marker for monitoring negative outcome.

No abstract

Background/aim: COVID-19 cases originated in Wuhan and it has become a global problem. The purpose of study to examine the rate of re-hospitalisation within 30 days after the completion of medical treatments for patients suffering from COVID-19. Materials and methods: In this study, the results of COVID-19 patients who were re-admitted to the hospital within 30 days were examined. The general and clinical characteristics of the patients and laboratory results were evaluated using parametric and nonparametric tests. Results: Included in this study were 22 patients, comprising 14 males and 8 females, with re-hospitalisation rate within 30 days and a diagnosis of COVID-19 that was 0.6%. The mean age of the patients who were re-hospitalised was 56.45 years. The major clinical symptoms of the patients who were re-hospitalised, respectively, were cough, shortness of breath, fever. When the levels from the first hospitalisation and the second hospitalisation were compared, an increase in the LYM count and N/L ratio was detected and the difference was statistically significant. Conclusion: A holistic patient assessment and care approach should be adopted by evaluating the symptomatic complaints as well as the comorbidities of the patients, so as to reduce the number of re-hospitalisations.